Shanghai Pharmaceuticals Holding Co. Ltd.’s US$402m H-share placement in Hong Kong

Michael Patrini

Freshfields Bruckhaus Deringer has advised Shanghai Pharmaceuticals Holding Co. Ltd. (‘Shanghai Pharma’) on its placement of approximately 153m new H-shares on the Hong Kong Stock Exchange….

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Michael Patrini

…

This content is for Standard 1 Year members only.
Login Join Now